ResearchI am interested in clinical and population-based research related to neuroimmunological diseases, focused on multiple sclerosis and neuromyelitis optica.
I perform research with collaborators in Asia and Africa on new technological interventions for neurological disorders. This work concentrates on the emerging burden of non-communicable neurological disorders in vulnerable populations, most notably including stroke, epilepsy, and cognitive disorders.
My research has been supported by the Grand Challenges Canada, Bill & Melinda Gates Foundation, Polio Eradication Initiative/World Health Organization, American Brain Foundation, Canadian Institute of Health Research, United Nations High Commissioner for Refugees, Thrasher Research Foundation, and others.
Mateen FJ, Muralidharan R, Carone M, van de Beek D, Harrison DM, Aksamit AJ, Gould MS, Clifford DB, Nath A. Progressive multifocal leukoencephalopathy in transplant recipients. Ann Neurol 2011;70:305-22.
Shinohara RT, Goldsmith J, Mateen FJ, Crainiceanu C, Reich DS. Predicting breakdown of blood-brain barrier in multiple sclerosis without contrast agents. AJNR Am J Neuroradiol 2012;33:1586-90.
Mateen FJ, Zubkov AY, Muralidharan R, Fugate JE, Rodriguez FJ, Winters JL, Petty GW. Susac syndrome: clinical characteristics and treatment in 29 new cases. Eur J Neurol 2012;19:800-11.
Mateen FJ, Mills EJ. Aging and HIV-related cognitive loss. JAMA 2012;308:349-50.
Mateen FJ, Josephs KA, Trenerry MR, Felmlee-Devine MD, Weaver AL, Carone M, White RD. Long term cognitive outcomes following out-of-hospital cardiac arrest: a population-based study. Neurology 2011;77:1438-45.
Mateen FJ, Muralidharan R, Shinohara RT, Parisi JE, Schears GJ, Wijdicks EF. Neurological injury in adults treated with extracorporeal membrane oxygenation. Arch Neurol 2011;68:1543-9.
Mateen FJ. Neurological disorders in complex humanitarian emergencies and natural disasters. Ann Neurol 2010;68:282-94.